|
1
|
Warrell RP Jr, de Thé H, Wang ZY and Degos
L: Acute promyelocytic leukemia. N Engl J Med. 329:177–189. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lo-Coco F and Cicconi L: History of acute
promyelocytic leukemia: A tale of endless revolution. Mediterr J
Hematol Infect Dis. 3:e20110672011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grignani F, Ferrucci PF, Testa U, Talamo
G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C,
Nicoletti I, et al: The acute promyelocytic leukemia-specific
PML-RAR alpha fusion protein inhibits differentiation and promotes
survival of myeloid precursor cells. Cell. 74:423–431. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laurenzana A, Pettersson F and Miller WH
Jr: Role of PML-RARα in the pathogenesis of APL. Drug Discov Today
Dis Mech. 3:499–505. 2006. View Article : Google Scholar
|
|
5
|
Lane AA and Ley TJ: Neutrophil elastase
cleaves PML-RARalpha and is important for the development of acute
promyelocytic leukemia in mice. Cell. 115:305–318. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lane AA and Ley TJ: Neutrophil elastase is
important for PML-retinoic acid receptor alpha activities in early
myeloid cells. Mol Cell Biol. 25:23–33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
di Masi A, Leboffe L, De Marinis E, Pagano
F, Cicconi L, Rochette-Egly C, Lo-Coco F, Ascenzi P and Nervi C:
Retinoic acid receptors: From molecular mechanisms to cancer
therapy. Mol Aspects Med. 41:1–115. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang ZY and Chen Z: Acute promyelocytic
leukemia: From highly fatal to highly curable. Blood.
111:2505–2515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang ME, Ye YC, Chen SR, Chai JR, Lu JX,
Zhao L, Gu LJ and Wang ZY: Use of all-trans retinoic acid in the
treatment of acute promyelocytic leukemia. Blood. 72:567–572.
1988.PubMed/NCBI
|
|
10
|
Breccia M, Cicconi L and Lo-Coco F: ATRA+
ATO: Has a new standard of care been established in low-risk acute
promyelocytic leukaemia? Curr Opin Hematol. 21:95–101. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iland HJ and Seymour JF: Role of arsenic
trioxide in acute promyelocytic leukemia. Curr Treat Options Oncol.
14:170–184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JH, Qiao B, Panageas KS, Schymura MJ,
Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM and Tallman
MS: Early death rate in acute promyelocytic leukemia remains high
despite all-trans retinoic acid. Blood. 118:1248–1254. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
De Braekeleer E, Douet-Guilbert N and De
Braekeleer M: RARA fusion genes in acute promyelocytic leukemia: A
review. Expert Rev Hematol. 7:347–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Soprano DR, Qin P and Soprano KJ: Retinoic
acid receptors and cancers. Annu Rev Nutr. 24:201–221. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang H, Zhong L, Jiang KL, Zhu XY, Ma PP,
Yang XQ and Liu BZ: Location verification of NLS-RARα protein in
infected NB4 cell line with adenovirus Ad-NE. Chin J Cell Biol.
36:331–337. 2014.(In Chinese).
|
|
16
|
Marshall KS, Cohen MJ, Fonseca GJ,
Todorovic B, King CR, Yousef AF, Zhang Z and Mymryk JS:
Identification and characterization of multiple conserved nuclear
localization signals within adenovirus E1A. Virology.
454-455:206–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Z, Wu T, Zhao F, Lau A, Birch CM and
Zhang DD: KPNA6 (Importin {alpha}7)-mediated nuclear import of
Keap1 represses the Nrf2-dependent antioxidant response. Mol Cell
Biol. 31:1800–1811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rizzatti EG, Garcia AB, Portieres FL,
Silva DE, Martins SL and Falcão RP: Expression of CD117 and CD11b
in bone marrow can differentiate acute promyelocytic leukemia from
recovering benign myeloid proliferation. Am J Clin Pathol.
118:31–37. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cumberbatch M, Tang X, Beran G, Eckersley
S, Wang X, Ellston RP, Dearden S, Cosulich S, Smith PD, Behrens C,
et al: Identification of a subset of human non-small cell lung
cancer patients with high PI3Kβ and low PTEN expression, more
prevalent in squamous cell carcinoma. Clin Cancer Res. 20:595–603.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie X, Tang B, Zhou J, Gao Q and Zhang P:
Inhibition of the PI3K/Akt pathway increases the chemosensitivity
of gastric cancer to vincristine. Oncol Rep. 30:773–782.
2013.PubMed/NCBI
|
|
22
|
Henriksson M and Lüscher B: Proteins of
the Myc network: Essential regulators of cell growth and
differentiation. Adv Cancer Res. 68:109–182. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wray J, Kalkan T, Gomez-Lopez S, Eckardt
D, Cook A, Kemler R and Smith A: Inhibition of glycogen synthase
kinase-3 alleviates Tcf3 repression of the pluripotency network and
increases embryonic stem cell resistance to differentiation. Nat
Cell Biol. 13:838–845. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ougolkov AV and Billadeau DD: Targeting
GSK-3: A promising approach for cancer therapy? Future Oncol.
2:91–100. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Diehl JA, Cheng M, Roussel MF and Sherr
CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis
and subcellular localization. Gene Dev. 12:3499–3511. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiao J, Paul P, Lee S, Qiao L, Josifi E,
Tiao JR and Chung DH: PI3K/AKT and ERK regulate retinoic
acid-induced neuroblastoma cellular differentiation. Biochem Biophs
Res Commun. 424:421–426. 2012. View Article : Google Scholar
|
|
27
|
Kim JM, Yoon M, Kim J and Kim SS, Kang I,
Ha J and Kim SS: Phosphatidylinositol 3-kinase regulates
differentiation of H9c2 cardiomyoblasts mainly through the protein
kinase B/Akt-independent pathway. Arch Biochem Biophys. 367:67–73.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ozpolat B, Akar U, Steiner M,
Zorrilla-Calancha I, Tirado-Gomez M, Colburn N, Danilenko M,
Kornblau S and Berestein GL: Programmed cell death-4 tumor
suppressor protein contributes to retinoic acid-induced terminal
granulocytic differentiation of human myeloid leukemia cells. Mol
Cancer Res. 5:95–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Srinivas H, Xia D, Moore NL, Uray IP, Kim
H, Ma L, Weigel NL, Brown PH and Kurie JM: Akt phosphorylates and
suppresses the transactivation of retinoic acid receptor alpha.
Biochem J. 395:653–662. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang K, Yang X, Ma P, Wang H, Zhu X, Liu
B and Zhong L: NLS-RARα: A novel transcriptional factor. Oncol
Lett. (In press).
|
